Arquivamento definitivo - Art. 33 da LPI
#11.1.1
05/02/2023
RPI 2730
Application data
Number
112021008082Type
Filing
Publication
PCT
IB2019059586 The application was abandoned: examination was not requested within the 36 months following the 11/07/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 05/02/2023. We update with every new RPI gazette, published weekly.
Applicants
CRISPR THERAPEUTICS AG
CH
Inventors
J. S. (pessoa física)
US
J. T. (pessoa física)
US
IPC Classification
Priority claims
US
62/756,723 · 11/07/2018
Abstract
TERAPIA CONTRA O CÂNCER COM CÉLULAS IMUNITÁRIAS ANTI-LIV1. A presente invenção refere-se, em algumas modalidades, a métodos e composições (por exemplo, composições celulares) para o tratamento de câncer, tais como malignidades LIV1+.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
05/02/2023
RPI 2730
#11.1
02/14/2023
RPI 2719
#1.3
08/10/2021
RPI 2640
#1.1
05/11/2021
RPI 2627
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.